National Comprehensive Cancer Network

|
|
|
|
For Patients

About NCCN

Cervical Cancer Screening Panel

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Nadeem R. Abu-Rustum, MD

None

None

None

None

7/1/2009

Susana M. Campos, MD, MPH, MS

None

None

None

None

1/2/2009

Mary Dwyer Rosario, MS

None

None

None

None

7/1/2009

Patrick J. Fahey, MD

None

None

None

None

7/7/2009

Lauren Gallagher, PhD

None

None

None

None

8/28/2009

Anna Giuliano, PhD

       

Pending

Benjamin E. Greer, MD

None

None

None

None

11/16/2009

Kristina M Gregory, RN, MSN, OCN

None

None

None

None

8/21/2009

Miranda Hughes, PhD

None

None

Myriad Genetic Laboratories, Inc.;
Affymetrix;
Qiagen NV

None

7/21/2009

Howard W. Jones, MD

None

Cytyc Health Corporation;
Merck & Co., Inc.;
Digene Corporation

None

None

11/16/2009

Subodh M. Lele, MD

None

None

None

None

9/30/2009

Richard W. Lieberman, MD, FACOG, FACP

None

None

None

None

9/28/2009

Joan S McClure, MS

None

None

None

None

9/28/2009

Mark A. Morgan, MD, FACOG, FACS

None

None

None

None

11/16/2009

Edward E. Partridge, MD

None

None

None

None

11/16/2009

R. Kevin Reynolds, MD

None

None

None

None

9/28/2009

Helen E Rhodes, MD

None

None

None

None

11/16/2009

Diljeet K. Singh, MD, DrPH

None

None

None

None

9/28/2009

Karen Smith-McCune, MD, PhD

None

None

None

None

11/16/2009

Nelson Teng, MD, PhD

GOG

None

None

None

11/16/2009

Cornelia Liu Trimble, MD

None

Merck & Co., Inc.

None

None

1/2/2009

Fidel Valea, MD

None

Merck & Co., Inc.;
Digene (Qiagen)

None

None

11/16/2009

Sharon Wilczynski, MD

None

None

None

None

9/29/2009

Johnny Yap, MD

       

Pending

 

NCCN Website Supporters